Natural Killer (NK) Cell Treatment
Natural Killer cells (also known as NK cells) are a type of white blood cell that play a vital role in rejecting and eliminating virally infected and tumor cells. According to studies, NK cells’ ability to destroy cancer cells is almost 100 times higher than that of other white blood cells. NK cells gradually decrease with age, which is why older people are prone to chronic diseases and cancer. But new technology developments have made it possible to extract NK cells from the body, multiply and strengthen them, before injecting back into patients to increase their chances of surviving cancer.
Lymphokine-Activated Killer (LAK) Cell Treatment
Technological advancements have enabled scientists to improve the quality and proliferation of white blood cells. The process involves stimulating white blood cells with cytokine to turn them into Lymphokine-Activated Killer (LAK) cells with a high potential to fight the growth and multiplication of cancer cells. LAK cells also help improve the immune system.
Dendritic Cell (DC) Vaccine
Cell therapy is a promising approach to cancer treatment. It can be used in combination with chemotherapy to lessen the side effects and improve outcomes. However, cell therapy isn’t an option for the majority of cancer patients due to its high costs. Dendritic Cell (DC) vaccination is a great alternative to cell therapy. Producing a DC vaccine requires a sample of the patient’s white blood cells, from which dendritic cells will be isolated and matured outside of the body. The dendritic cells are then injected back into the patient, where they will interact with T cells to stimulate a highly targeted immune response against the cancer cells.